A critical review of reports of endogenous psychedelic N, N-dimethyltryptamines in humans: 1955-2010.
Steven A. Barker, Ethan H. Mcilhenny, Rick J. Strassman
Drug Testing and Analysis 2012 DOI: 10.1002/dta.422 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review Peer reviewed |
|---|---|
| Topics | 5-MeO-DMT DMT |
| Keywords | Endogenous psychedelics Natural psychedelics Internal psychedelics Bodily psychedelics Endogenous psychoactives Neuropsychedelics Brain chemistry Neurobiology Biochemical neuroscience Human neurochemistry Scientific review Literature review Research review Meta-analysis Academic review Critical assessment Human biochemistry Human physiology Body chemistry Physiological chemistry Biofluids Bodily substances |
| Citations | 143 |
| Key findings | Three indole alkaloids with psychedelic activity—DMT, bufotenine, and 5-MeO-DMT—have been detected as endogenous substances in human body fluids, but past methods have limitations that newer findings may overcome. |
Abstract
Three indole alkaloids that possess differing degrees of psychotropic/psychedelic activity have been reported as endogenous substances in humans; N,N-dimethyltryptamine (DMT), 5-hydroxy-DMT (bufotenine, HDMT), and 5-methoxy-DMT (MDMT). We have undertaken a critical review of 69 published studies reporting the detection or detection and quantitation of these compounds in human body fluids. In reviewing this literature, we address the methods applied and the criteria used in the determination of the presence of DMT, MDMT, and HDMT. The review provides a historical perspective of the research conducted from 1955 to 2010, summarizing the findings for the individual compounds in blood, urine, and/or cerebrospinal fluid. A critique of the data is offered that addresses the strengths and weaknesses of the methods and approaches to date. The review also discusses the shortcomings of the existing data in light of more recent findings and how these may be overcome. Suggestions for the future directions of endogenous psychedelics research are offered.
In the evidence
This study is part of the evidence base for a synthesis in the library. Here is how each one recorded it.
-
State of the evidence: 5-MeO-DMT Unclear
Reports that 5-MeO-DMT has been detected as an endogenous substance in human body fluids, while noting methodological limitations of past detection studies.
Synthesized
Comparable studies
Other systematic reviews and meta-analyses on 5-MeO-DMT, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Short-term safety and tolerability profile of 5-methoxy-N,N-dimethyltryptamine in human subjects: a systematic review of clinical trials. Healthy volunteers and patients with treatment-resistant depression | 2024 | Systematic review | n = 78 |
| Clinical Pharmacokinetics of N,N-Dimethyltryptamine (DMT): A Systematic Review and Post-hoc Analysis. Humans | 2025 | Systematic review | |
| Efficacy of N, N-dimethyltryptamine (DMT) psychedelic therapy for substance misuse: A systematic review and meta-analysis Individuals with substance misuse | 2026 | Systematic review and meta-analysis | |
| Clinical pharmacokinetics of N,N-dimethyltryptamine (DMT): a systematic review and post-hoc analysis Humans | 2025 | Systematic review | |
| Pharmacological, clinical, and translational evidence for N,N-dimethyltryptamine, 5-methoxy-N,N-dimethyltryptamine, and zalsupindole: a systematic review. | 2026 | Systematic review |
Citations in the library
Cited by 94
- Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors Science February 16, 2023
- The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology August 1, 2015
- Neuropharmacology of N,N-dimethyltryptamine Brain Research Bulletin April 30, 2016
- The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization. Frontiers in Pharmacology March 2, 2016
- Clinical applications of hallucinogens: A review. Experimental and Clinical Psychopharmacology August 1, 2016
and 89 more in the library
Cites 28
- The Hallucinogen N,N -Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator Science February 13, 2009
- Dose-Response Study of N,N-Dimethyltryptamine in Humans Archives of General Psychiatry February 1, 1994
- Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics Journal of Pharmacology and Experimental Therapeutics June 18, 2003
- Clinical investigations of the therapeutic potential of ayahuasca: rationale and regulatory challenges. Pharmacology & Therapeutics May 1, 2004
- Human psychopharmacology of N,N-dimethyltryptamine Behavioural Brain Research December 1, 1995
and 23 more in the library